THYROID 2019 10.1089/thy.2019.0022
Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study
Lee1, EK; Kim, SM; Kim, BH; Kim, MJ; Lim, DJ; Kim, MH; Shin, DY; Kang, HC; Ahn, BC; Kim, SW; Ahn, HY; Park, YJ

SCI REP-UK 2019 10.1038/s41598-019-55370-w
Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer
Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH

THYROID 2019 10.1089/thy.2019.0261
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis
Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH

EUR J NUTR 2019 10.1007/s00394-018-1837-4
Non-immune-related hypothyroidism and its relationship with excess iodine
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH

EUR ARCH OTO-RHINO-L 2019 10.1007/s00405-019-05702-3
Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma
Kim1, BY; Choi, N; Kim, SW; Jeong, HS; Chung, MK; Son, YI

THYROID 2019 10.1089/thy.2019.0091
Increased Morbidity of Major Depressive Disorder After Thyroidectomy: A Nationwide Population-Based Study in South Korea
Choi1, KW; Kim, Y; Fava, M; Mischoulon, D; Na, EJ; Kim, SW; Shin, MH; Chung, MK; Jeon, HJ

HEAD NECK-J SCI SPEC 2019 10.1002/hed.25721
Prediction of follicular thyroid carcinoma associated with distant metastasis in the preoperative and postoperative model
Kim1, H; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Park, KW; Lim, Y

THYROID 2019 10.1089/thy.2018.0541
Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL

ENDOCRINE 2019 10.1007/s12020-018-1807-x
Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin
Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW

EUR J NUTR 2019 10.1007/s00394-017-1587-8
Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015
Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH

ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014
Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma
Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029
Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study
Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG

J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386
Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma
Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH

THYROID 2018 10.1089/thy.2018.0263
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea
Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study
Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG

SCI REP-UK 2018 10.1038/s41598-018-31955-9
Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance
Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002
Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles
Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH

BRIT J SURG 2018 10.1002/bjs.10830
Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma
Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH

THYROID 2018 10.1089/thy.2017.0550
Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea
Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW

KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051
Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area
Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY

ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021
Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis
Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH

EUR J NUTR 2018 10.1007/s00394-016-1370-2
Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area
Kim1, HJ; Park, HK; Byun, DW; Suh, K; Yoo, MH; Min, YK; Kim, SW; Chung, JH

HISTOPATHOLOGY 2018 10.1111/his.13401
Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma
Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL

J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

PLoS One 2018 10.1371/journal.pone.0190738
Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015)
Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW

BRIT J SURG 2018 10.1002/bjs.10655
Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH

THYROID 2018 10.1089/thy.2017.0214
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer
Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG

Oncoimmunology 2018 10.1080/2162402X.2017.1375642
Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer
Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH

ONCOTARGET 2017 10.18632/oncotarget.22430
Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH

SCI REP-UK 2017 10.1038/s41598-017-17176-6
Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer
Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW

Cancer Med 2017 10.1002/cam4.1160
Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size
Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH

ENDOCRINE 2017 10.1007/s12020-017-1381-7
Validation of dynamic risk stratification in pediatric differentiated thyroid cancer
Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH

ENDOCRINE 2017 10.1007/s12020-017-1363-9
Hormetic effect of triiodothyronine in metabolically healthy obese persons
Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK

CLIN ENDOCRINOL 2017 10.1111/cen.13344
Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer
Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW

ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004
Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma
Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH

ENDOCRINE 2017 10.1007/s12020-017-1340-3
Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer
Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH

THYROID 2017 10.1089/thy.2016.0648
Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma
Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH

PLoS One 2017 10.1371/journal.pone.0182090
Subclinical thyroid dysfunction and risk of carotid atherosclerosis
Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW

Eur J Endocrinol. 2017 Apr;176(4):441-450. doi: 10.1530/EJE-16-0734. Epub 2017 Jan 18.
Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study
Kim HJ11, Bae JC2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Jae Hwan J3, Kim JH4, Min YK4, Kim SW4, Chung JH5.

Eur J Nutr. 2017 Apr;56(3):965-971. doi: 10.1007/s00394-015-1144-2. Epub 2016 Jan 8.
Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area
Kim HJ11, Kim NK2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Min YK2, Kim SW2, Chung JH3.

Endocrine. 2017 Mar;55(3):944-953. doi: 10.1007/s12020-016-1221-1. Epub 2017 Jan 2.
TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects
Jun JE11, Jin SM1, Jee JH2, Bae JC3, Hur KY1, Lee MK1, Kim SW1, Kim JH4,5.

Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2.
Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?
Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.

Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12.
Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area
Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):625-633. doi: 10.1210/jc.2016-2287.
Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study
Hwangbo Y11,2, Kim JM3, Park YJ2, Lee EK1, Lee YJ1, Park DJ2, Choi YS4, Lee KD5, Sohn SY6, Kim SW6, Chung JH6, Lim DJ7, Kim MH7, Kim MJ3, Jo YS8, Shong MH8, Koong SS9, Hahm JR10, Jung JH10, Yi KH2,11.

Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5.
The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects
Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.

Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421.
Comprehensive screening for PD-L1 expression in thyroid cancer
Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.

Thyroid. 2017 Jan;27(1):29-38. doi: 10.1089/thy.2016.0171. Epub 2016 Dec 9.
Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study
Jun JE11, Jee JH2, Bae JC3, Jin SM1, Hur KY1, Lee MK1, Kim TH1, Kim SW1, Kim JH1.

PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017.
Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication
Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.

Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63.
First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant
Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.

Nutrients. 2016 Dec 8;8(12). pii: E797.
A Prospective Study on Serum Methylmalonic Acid and Homocysteine in Pregnant Women
Choi R11, Choi S2, Lim Y3, Cho YY4, Kim HJ5, Kim SW6, Chung JH7, Oh SY8, Lee SY9.

Nutrients. 2016 Nov 23;8(11). pii: E749.
A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women
Choi R11, Sun J2, Yoo H3, Kim S4, Cho YY5, Kim HJ6, Kim SW7, Chung JH8, Oh SY9, Lee SY10,11.

Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7.
Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence
Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.

Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15.
TERT promoter mutations and long-term survival in patients with thyroid cancer
Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.

Ann Lab Med. 2016 Sep;36(5):413-9. doi: 10.3343/alm.2016.36.5.413.
Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer
Cho YY11, Chun S2, Lee SY2, Chung JH1, Park HD3, Kim SW4.

Am J Clin Oncol. 2016 Aug;39(4):374-8. doi: 10.1097/COC.0000000000000072.
Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma The First Report in Nonwestern Countries
Joung JY11, Choi JH, Cho YY, Kim NK, Sohn SY, Kim SW, Chung JH.

Histopathology. 2016 Jul;69(1):45-53. doi: 10.1111/his.12902. Epub 2016 Jan 11.
Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications
Joung JY11, Kim TH1, Jeong DJ1, Park SM1, Cho YY1, Jang HW2, Jung YY3, Oh YL3, Yim HS4, Kim YL4, Chung JH1, Ki CS5, Kim SW1.

Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18.
Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques
Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.

Thyroid. 2016 May;26(5):672-82. doi: 10.1089/thy.2015.0527.
Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer
Sohn SY11, Park WY2,3, Shin HT2, Bae JS2, Ki CS4, Oh YL5, Kim SW6, Chung JH6.

Eur J Nutr. 2016 Mar;55(2):469-75. doi: 10.1007/s00394-015-0864-7. Epub 2015 Mar 7.
Iodine status in healthy pregnant women in Korea: a first report
Cho YY11, Kim HJ1,2, Oh SY3, Choi SJ3, Lee SY4, Joung JY1, Jeong DJ1, Sohn SY1, Chung JH1, Roh CR5, Kim SW6.

PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015.
A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels
Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.

Thyroid. 2015 Aug;25(8):927-34. doi: 10.1089/thy.2014.0557. Epub 2015 Jul 2.
Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea
Seo GH11, Cho YY2, Chung JH2, Kim SW2.

Nutrients. 2015 May 11;7(5):3427-48. doi: 10.3390/nu7053427.
High Prevalence of Vitamin D Deficiency in Pregnant Korean Women: The First Trimester and the Winter Season as Risk Factors for Vitamin D Deficiency
Choi R11, Kim S2, Yoo H3, Cho YY4, Kim SW5, Chung JH6, Oh SY7, Lee SY8.

Ann Lab Med. 2015 May;35(3):387-9. doi: 10.3343/alm.2015.35.3.387. Epub 2015 Apr 1.
Identification of p.Glu131Lys Mutation in the IHH Gene in a Korean Patient With Brachydactyly Type A1
Jang MA11, Kim OH2, Kim SW3, Ki CS1.

Head Neck. 2015 May;37(5):650-4. doi: 10.1002/hed.23650. Epub 2014 Apr 10.
Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma
Kim HJ11, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH.

Eur J Clin Nutr. 2015 Mar;69(3):361-6. doi: 10.1038/ejcn.2014.284. Epub 2015 Feb 4.
Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass
Park SM11, Joung JY1, Cho YY1, Sohn SY1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK1.

Endocr J. 2015;62(3):243-50. doi: 10.1507/endocrj.EJ14-0384. Epub 2014 Dec 4.
Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma
Kim HJ11, Lee JI, Cho YY, Lee SY, Kim JH, Jung BC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim JH.

Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15.
Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea
Cho YY11, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.

Head Neck. 2014 Dec;36(12):1695-700. doi: 10.1002/hed.23511. Epub 2014 Feb 27.
Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma
Kim HJ11, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.

Thyroid. 2014 Sep;24(9):1361-8. doi: 10.1089/thy.2014.0046. Epub 2014 Jun 30.
Effect of Iodine Restriction on Thyroid Function in Subclinical Hypothyroid Patients in an Iodine-Replete Area: A Long Period Observation in a Large-Scale Cohort
Joung JY11, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH.

Clin Chem Lab Med. 2014 Jul;52(7):e139-42. doi: 10.1515/cclm-2013-1007.
Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer
Woo HI1, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.

Asian Pac J Cancer Prev. 2014;15(12):5107-10.
Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association
Shin S11, Park SE, Kim SY, Hyun MK, Kim SW, Kwon JW, Kim Y, Kim WB, Na DG, Park HA, Sheen SS, Yi KH, Chang HS, Cho JJ, Chung JH.

Thyroid. 2014 May;24(5):872-7. doi: 10.1089/thy.2013.0238. Epub 2014 Mar 6.
The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment
Sohn SY11, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW.

Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3.
Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells
Jin SM11, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.

J Diabetes Investig. 2014 Feb 12;5(1):51-9. doi: 10.1111/jdi.12127. Epub 2013 Sep 2.
Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin
Chung HS11, Suh S2, Kim MY3, Kim SK3, Kim HK3, Lee JI3, Hur KY3, Kim JH3, Min YK3, Lee MS3, Kim KW3, Kim SW3, Chung JH3, Lee MK3.

Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1.
Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas
Sohn SY11, Kim HJ, Jang HW, Kim SW, Chung JH.

Korean J Intern Med. 2013 Nov;28(6):724-7. doi: 10.3904/kjim.2013.28.6.724. Epub 2013 Oct 29.
Postinfectious Guillain-Barre syndrome in a patient with methimazole-induced agranulocytosis
Cho YY11, Joung JY, Jeong H, Je D, Hong YS, Suh S, Kim SW.

Clin Endocrinol (Oxf). 2013 Sep;79(3):445. doi: 10.1111/cen.12131. Epub 2013 Apr 5.
Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma
Kim HJ1, Kim SW.

Thyroid. 2013 Jun;23(6):741-7. doi: 10.1089/thy.2012.0136.
Association Between Excessive Urinary Iodine Excretion and Failure of Radioactive Iodine Thyroid Ablation in Patients with Papillary Thyroid Cancer
Sohn SY11, Choi JY, Jang HW, Kim HJ, Jin SM, Kim SW, Suh S, Hur KY, Kim JH, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2013 Apr;78(4):614-20. doi: 10.1111/cen.12034.
Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma
Kim HJ11, Kim NK, Choi JH, Kim SW, Jin SM, Suh S, Bae JC, Min YK, Chung JH, Kim SW.

Endocr Res. 2013;38(2):89-97. doi: 10.3109/07435800.2012.723292.
ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF(V600E) Mutation Compared to That of Corresponding Normal Thyroid Tissues
Kim SW11, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.

Head Neck. 2013 Jan;35(1):E13-7. doi: 10.1002/hed.21784. Epub 2011 Nov 22.
Postoperative spindle cell nodule after thyroidectomy: A case mimicking recurrence with anaplastic transformation of thyroid cancer
Kim SW11, Oh YL, Choi JY, Lee JI, Chung JH, Kim JS.

Clin Endocrinol (Oxf). 2013 Jan;78(1):134-40. doi: 10.1111/j.1365-2265.2012.04506.x.
Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer
Kim HJ11, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM, Jang HW, Suh S, Min YK, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2012 Sep;77(3):459-64. doi: 10.1111/j.1365-2265.2012.04396.x.
Time trend in tumour size and characteristics of anaplastic thyroid carcinoma
Han JM11, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK.

J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12.
Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area
Lee ST11, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.

Head Neck. 2012 May;34(5):696-701. doi: 10.1002/hed.21808. Epub 2011 Jul 11.
Identification of a cut-off for the macis score to predict the prognosis of differentiated thyroid carcinoma in children and young adults
Jang HW11, Lee JI, Kim HK, Oh YL, Choi YL, Jin DK, Kim JH, Chung JH, Kim SW.

J Korean Surg Soc. 2012 May;82(5):271-80. doi: 10.4174/jkss.2012.82.5.271. Epub 2012 Apr 26.
Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays
Chung KW11, Kim SW, Kim SW.

Head Neck. 2012 Feb;34(2):201-6. doi: 10.1002/hed.21716. Epub 2011 Jun 29.
Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma
Kim HK11, Oh YL, Kim SH, Lee DY, Kang HC, Lee JI, Jang HW, Hur KY, Kim JH, Min YK, Chung JH, Kim SW.

Clin Endocrinol (Oxf). 2011 Dec;75(6):851-6. doi: 10.1111/j.1365-2265.2011.04157.x.
Daily urine iodine excretion while consuming a low-iodine diet in preparation for radioactive iodine therapy in a high iodine intake area
Kim HK11, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.

J Korean Med Sci. 2010 Sep;25(9):1368-71. doi: 10.3346/jkms.2010.25.9.1368. Epub 2010 Aug 12.
A Case of Resistance to Thyroid Hormone with Thyroid Cancer
Kim HK11, Kim D, Yoo EH, Lee JI, Jang HW, Tan AH, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

Health Qual Life Outcomes. 2010 Sep 15;8:101. doi: 10.1186/1477-7525-8-101.
Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea
Lee JI11, Kim SH, Tan AH, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

Head Neck. 2010 Sep;32(9):1161-6. doi: 10.1002/hed.21308.
DIFFERENCES IN SERUM THYROGLOBULIN MEASUREMENTS BY 3 COMMERCIAL IMMUNORADIOMETRIC ASSAY KITS AND LABORATORY STANDARDIZATION USING CERTIFIED REFERENCE MATERIAL 457 (CRM-457)
Lee JI11, Kim JY, Choi JY, Kim HK, Jang HW, Hur KY, Kim JH, Kim KW, Chung JH, Kim SW.

J Histochem Cytochem. 2010 Aug;58(8):731-40. doi: 10.1369/jhc.2010.955906. Epub 2010 Apr 26.
Pathologic Changes and Glucose Homeostasis According to Expression of Human Islet Amyloid Polypeptide in Type 2 Diabetic Patients
Park JY11, No HS, Ahn YR, Oh SH, Kim YS, Kim SY, Jang KT, Kim SW, Chung JH, Min YK, Heo JS, Choi SH, Choi DW, Lee MS, Lee MK, Kim JH, Kim KW.

J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700. doi: 10.1210/jc.2009-2795. Epub 2010 May 25.
BRAF(V600E) Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in a BRAF(V600E)-Prevalent Population
Kim SW11, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.

Clin Endocrinol (Oxf). 2010 Jul;73(1):114-8. doi: 10.1111/j.1365-2265.2009.03774.x. Epub 2009 Dec 29.
Usefulness of iodine/creatinine ratio from spot-urine samples to evaluate the effectiveness of low-iodine diet preparation for radioiodine therapy
Kim HK11, Lee SY, Lee JI, Jang HW, Kim SK, Chung HS, Tan AH, Hur KY, Kim JH, Chung JH, Kim SW.

Head Neck. 2010 Jan;32(1):68-75. doi: 10.1002/hed.21145.
SPURIOUS HYPERCALCITONINEMIA IN PATIENTS WITH NODULAR THYROID DISEASE INDUCED BY HETEROPHILIC ANTIBODIES
Kim JM11, Chung KW, Kim SW, Choi SH, Min HS, Kim JN, Won WJ, Kim SK, Lee JI, Chung JH, Kim SW.

없음
Somatic Mutational Analysis of MEN1 and Phenotypic Correlation in Sporadic Parathyroid Tumors